Inhalers – Pipeline Products by Stage of Development 16
Inhalers – Pipeline Products by Segment 17
Inhalers – Pipeline Products by Territory 18
Inhalers – Pipeline Products by Regulatory Path 20
Inhalers – Pipeline Products by Estimated Approval Date 21
Inhalers – Ongoing Clinical Trials 22
Inhalers Companies – Pipeline Products by Stage of Development 23
Inhalers – Pipeline Products by Stage of Development 26
1nhaler Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
Single-Use Dry Powder Inhaler – Product Status 29
Single-Use Dry Powder Inhaler – Product Description 29
Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
INBRIJA – Product Status 30
INBRIJA – Product Description 30
PLUMIAZ Nasal Spray Device – Product Status 31
PLUMIAZ Nasal Spray Device – Product Description 31
Acorda Therapeutics Inc – Ongoing Clinical Trials Overview 32
INBRIJA – Usability of Levodopa Cyclops Compared to INBRIJA During an Off Episode in Parkinson’s Disease Patients 33
Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
g60 Dry Powder Inhaler – Product Status 34
g60 Dry Powder Inhaler – Product Description 34
Aerami Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 35
AFINA Smart Inhaler – Product Status 35
AFINA Smart Inhaler – Product Description 35
Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36
resQhaler – Product Status 36
resQhaler – Product Description 36
AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37
Fentanyl TAIFUN Inhaler – Product Status 37
Fentanyl TAIFUN Inhaler – Product Description 37
AsMedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 38
Reusable Inhaler – Product Status 38
Reusable Inhaler – Product Description 38
Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 39
Ciprofloxacin Dry Powder Inhaler – Product Status 39
Ciprofloxacin Dry Powder Inhaler – Product Description 40
Claricare – Product Status 40
Claricare – Product Description 40
Bellerophon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Mark2 Device – Product Status 41
Mark2 Device – Product Description 41
Cambridge Healthcare Innovations Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
aeolus Dry-Powder Inhaler (DPI) – Product Status 42
aeolus Dry-Powder Inhaler (DPI) – Product Description 42
Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
Complex Inhaler – Product Status 43
Complex Inhaler – Product Description 43
Smart Inhaler – Product Status 44
Smart Inhaler – Product Description 44
Covinhaler LLP Pipeline Products & Ongoing Clinical Trials Overview 45
Pocket Inhaler – COVID-19 – Product Status 45
Pocket Inhaler – COVID-19 – Product Description 45
Creare LLC Pipeline Products & Ongoing Clinical Trials Overview 46
Intranasal Dry Powder Inhaler – Product Status 46
Intranasal Dry Powder Inhaler – Product Description 46
De Motu Cordis Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
DMC Inhaler – Product Status 47
DMC Inhaler – Product Description 47
De Motu Cordis Pty Ltd – Ongoing Clinical Trials Overview 48
DMC Inhaler – A Phase 1, 2-Part Study in Healthy Male and Female Participants; Part 1 – A Randomised, Double-Blind, Placebo-Controlled, Single Ascending Dose-Escalation Study of Inhaled DMC-IH1; Part 2 – An Open-Label, 3-Arm Study Assessing the Carryover Effects of Inhaled (DMC-IH1) and Intramuscular (EpiPen) Epinephrine 49
DMK Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 50
APC-4000 Fluticasone Dry Powder Inhaler – Product Status 50
APC-4000 Fluticasone Dry Powder Inhaler – Product Description 50
Drexel University Pipeline Products & Ongoing Clinical Trials Overview 51
BREATHE Inhaler – Product Status 51
BREATHE Inhaler – Product Description 51
Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview 52
Nasal Glucagon Delivery System – Product Status 52
Nasal Glucagon Delivery System – Product Description 52
Engage Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Staccato Alprazolam – Product Status 53
Staccato Alprazolam – Product Description 53
Findair Sp zoo Pipeline Products & Ongoing Clinical Trials Overview 54
FindAir ONE Smart Inhaler – Product Status 54
FindAir ONE Smart Inhaler – Product Description 54
Findair Sp zoo – Ongoing Clinical Trials Overview 55
FindAir ONE Smart Inhaler – Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease 56
FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 57
Smart Inhaler – Product Status 57
Smart Inhaler – Product Description 57
Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
Tiogiva – Product Status 58
Tiogiva – Product Description 58
GSK plc Pipeline Products & Ongoing Clinical Trials Overview 59
Gemini Multi-Dose Combination Inhaler – Product Status 59
Gemini Multi-Dose Combination Inhaler – Product Description 59
Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 60
Papillon DPI – Product Status 60
Papillon DPI – Product Description 60
Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview 61
ICOcap – Product Status 61
ICOcap – Product Description 61
ICOone – Product Status 62
ICOone – Product Description 62
ICOone – Oxytocin – Product Status 62
ICOone – Oxytocin – Product Description 63
ICOpre – Product Status 63
ICOpre – Product Description 63
ICOres – Product Status 64
ICOres – Product Description 64
Multi-Dose Delivery Device – Product Status 64
Multi-Dose Delivery Device – Product Description 65
Iconovo AB – Ongoing Clinical Trials Overview 66
ICOone – A Feasibility Study with Affilogic for the Development of Inhalable Nanofitin-based Biotherapies 67
ICOone – Oxytocin – A Randomized, Single-Center, Partially Single-Blind Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Single and Repeated Doses of Oxytocin Administered via Inhalation or Intravenous or Intramuscular Administration in Healthy Female Participants 68
Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 69
Dry Powder Inhaler 1 – Product Status 69
Dry Powder Inhaler 1 – Product Description 69
Dry Powder Inhaler 2 – Product Status 70
Dry Powder Inhaler 2 – Product Description 70
Tiotropium DPI – Product Status 70
Tiotropium DPI – Product Description 70
MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview 71
Afrezza – Pediatric Use – Product Status 71
Afrezza – Pediatric Use – Product Description 72
Afrezza Inhaler – Product Status 72
Afrezza Inhaler – Product Description 72
Treprostinil Technosphere – Product Status 73
Treprostinil Technosphere – Product Description 73
MannKind Corp – Ongoing Clinical Trials Overview 74
Afrezza Inhaler – INHALE-3: A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Inhaled Insulin (Afrezza) Combined with Insulin Degludec Versus Usual Care in Adults with Type 1 Diabetes 75
Medihale Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76
Toucan Multi-Dose Inhaler – Product Status 76
Toucan Multi-Dose Inhaler – Product Description 76
Monash University Pipeline Products & Ongoing Clinical Trials Overview 77
Aerosol Delivery System – Product Status 77
Aerosol Delivery System – Product Description 77
Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 78
NKTR-061 – Product Status 78
NKTR-061 – Product Description 78
North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 79
Smart Inhaler System – Product Status 79
Smart Inhaler System – Product Description 79
Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 80
Atectura Breezhaler – Product Status 80
Atectura Breezhaler – Product Description 81
Enerzair Breezhaler – Product Status 81
Enerzair Breezhaler – Product Description 81
Next Generation Breezhaler Inhaler – Product Status 82
Next Generation Breezhaler Inhaler – Product Description 82
Novartis AG – Ongoing Clinical Trials Overview 83
Enerzair Breezhaler – A 24-week Prospective, Open-label, Multicenter, Single-arm, Observational Regulatory Post-Marketing Surveillance (rPMS) Study in Real-world Setting (Mandatory by Local HA Regulation) for Enerzair (QVM149 150/50/80 µg o.d. and QVM149 150/50/160 µg o.d. Via Breezhaler) 84
Enerzair Breezhaler – A Double-dummy, Double-blind, Randomized, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Compared to Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. 84
Enerzair Breezhaler – Comparison of Enerziar and Trelegy, Single Inhaler Triple Therapy (SITT), in Asthma 84
Atectura Breezhaler – A 24-week Prospective, Open-label, Multicenter, Single-arm Regulatory Post-Marketing Surveillance (rPMS) Study in Real-world Setting (Mandatory by Local HA Regulation) for Atectura (QMF149 150/80 µg o.d., QMF149 150/160 µg o.d. and QMF149 150/320 µg o.d. Via Breezhaler) 85
Atectura Breezhaler – A Double-dummy, Double-blind, Randomized, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Compared to Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. 85
Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview 86
GelVac Intranasal Powder Vaccine Delivery System – Product Status 86
GelVac Intranasal Powder Vaccine Delivery System – Product Description 86
NanoGENT – Product Status 87
NanoGENT – Product Description 87
OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 88
Inspiromatic – Product Status 88
Inspiromatic – Product Description 88
OtiTopic Inc Pipeline Products & Ongoing Clinical Trials Overview 89
ASPRIHALE – Product Status 89
ASPRIHALE – Product Description 89
OtiTopic Inc – Ongoing Clinical Trials Overview 90
ASPRIHALE – A Phase I, Single-dose, Open-label, Pilot Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Inhalation Powder with Non-enteric-coated Chewable Aspirin in Healthy Adults 91
Pai Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 92
Inhaled Delivery System – Tuberculosis – Product Status 92
Inhaled Delivery System – Tuberculosis – Product Description 92
Phargentis SA Pipeline Products & Ongoing Clinical Trials Overview 93
Glide DPI – Product Status 93
Glide DPI – Product Description 93
Indacaterol/Glycopyrronium DPI – Product Status 94
Indacaterol/Glycopyrronium DPI – Product Description 94
Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
Orbital Dry Powder Inhaler – Product Status 95
Orbital Dry Powder Inhaler – Product Description 95
Pneuma Respiratory Inc Pipeline Products & Ongoing Clinical Trials Overview 96
PNEUMAHALER – Product Status 96
PNEUMAHALER – Product Description 96
Pure Scientific Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 97
PST Closed Loop Heliox Inhaler – Product Status 97
PST Closed Loop Heliox Inhaler – Product Description 97
PureIMS BV Pipeline Products & Ongoing Clinical Trials Overview 98
Amikacin Cyclops – Product Status 98
Amikacin Cyclops – Product Description 98
Epinephrine Cyclops – Product Status 99
Epinephrine Cyclops – Product Description 99
Levodopa Cyclops – Product Status 99
Levodopa Cyclops – Product Description 100
Tobramycin Cyclops – Product Status 100
Tobramycin Cyclops – Product Description 100
PureIMS BV – Ongoing Clinical Trials Overview 101
Levodopa Cyclops – Usability of Levodopa Cyclops Compared to INBRIJA During an Off Episode in Parkinson’s Disease Patients 102
Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 103
Dry Powder Inhaler – Product Status 103
Dry Powder Inhaler – Product Description 103
Resolve Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview 104
Resolve Go MD – Product Status 104
Resolve Go MD – Product Description 104
Resolve MD – Product Status 104
Resolve MD – Product Description 105
Resolve Mini MD – Product Status 105
Resolve Mini MD – Product Description 105
Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 106
RT234 AOS DPI – Product Status 106
RT234 AOS DPI – Product Description 106
Respirent Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 107
Flovent Diskus – Generic Version – Product Status 107
Flovent Diskus – Generic Version – Product Description 107
Respirent Pharmaceuticals Co Ltd – Ongoing Clinical Trials Overview 108
Flovent Diskus – Generic Version – A Randomized, Single-dose, Open Label, Two-treatment, Two-sequence, Two-period, Crossover Study Under Fasting Conditions to Examine the Bioequivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals Vs. FLOVENT DISKUS 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers 109
Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 110
Pronto Allergy Relief – Product Status 110
Pronto Allergy Relief – Product Description 110
Pronto Focus – Product Status 111
Pronto Focus – Product Description 111
Pronto Nausea Relief – Product Status 111
Pronto Nausea Relief – Product Description 112
Pronto Sleep Performance – Product Status 112
Pronto Sleep Performance – Product Description 112
Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview 113
Solis Multi-Dose Dry Powder Inhaler – Product Status 113
Solis Multi-Dose Dry Powder Inhaler – Product Description 113
Unit-Dose Dry Powder Inhaler – Product Status 114
Unit-Dose Dry Powder Inhaler – Product Description 114
Seng Vital International GmbH Pipeline Products & Ongoing Clinical Trials Overview 115
Cannamed – Product Status 115
Cannamed – Product Description 115
Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview 116
Dry Powder Inhaler – Product Status 116
Dry Powder Inhaler – Product Description 116
Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview 117
STS101 Dry Powder Delivery Device – Product Status 117
STS101 Dry Powder Delivery Device – Product Description 117
Sinsin Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 118
BVA110 – Product Status 118
BVA110 – Product Description 118
DFA001 – Product Status 119
DFA001 – Product Description 119
Softhale NV Pipeline Products & Ongoing Clinical Trials Overview 120
Softhaler – Product Status 120
Softhaler – Product Description 120
Spyryx Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 121
SPX-250 Dry Powder Inhaler – Product Status 121
SPX-250 Dry Powder Inhaler – Product Description 121
Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview 122
AirDuo Digihaler – Product Status 122
AirDuo Digihaler – Product Description 123
ArmonAir Digihaler – Product Status 123
ArmonAir Digihaler – Product Description 123
Inhaler Device – Product Status 124
Inhaler Device – Product Description 124
ProAir Digihaler – Product Status 124
ProAir Digihaler – Product Description 125
Tidal Inhaler – Product Status 125
Tidal Inhaler – Product Description 125
Teva Pharmaceutical Industries Ltd – Ongoing Clinical Trials Overview 126
ProAir Digihaler – Utilizing Advances in Digital Inhaler Technology to Understand Heterogeneous Treatment Responses to Biologics in Severe Asthma 127
AirDuo Digihaler – Utilizing Advances in Digital Inhaler Technology to Understand Heterogeneous Treatment Responses to Biologics in Severe Asthma 128
Transpire Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 129
CNS Inhaler 1 – Product Status 129
CNS Inhaler 1 – Product Description 129
CNS Inhaler 2 – Product Status 130
CNS Inhaler 2 – Product Description 130
Dry Powder Inhaler (DPI) – Asthma COPD – Product Status 130
Dry Powder Inhaler (DPI) – Asthma COPD – Product Description 131
Dry Powder Inhaler (DPI) – COPD – Product Status 131
Dry Powder Inhaler (DPI) – COPD – Product Description 131
Oncology Inhaler – Product Status 132
Oncology Inhaler – Product Description 132
Soft Mist Inhaler (SMI) – COPD – Product Status 132
Soft Mist Inhaler (SMI) – COPD – Product Description 133
University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 134
Dry Powder Inhaler – Product Status 134
Dry Powder Inhaler – Product Description 134
University of Sydney Pipeline Products & Ongoing Clinical Trials Overview 135
Dry Powder Inhaler – Product Status 135
Dry Powder Inhaler – Product Description 135
University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 136
Dry Powder Drug Delivery System – Product Status 136
Dry Powder Drug Delivery System – Product Description 136
Uscom Ltd Pipeline Products & Ongoing Clinical Trials Overview 137
Spirosonic SmartSpacer – Product Status 137
Spirosonic SmartSpacer – Product Description 137
Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview 138
Digitally – Connected LOMI Device – Product Status 138
Digitally – Connected LOMI Device – Product Description 138
MRX006 – Multidose Combined DPI Inhaler – Product Status 139
MRX006 – Multidose Combined DPI Inhaler – Product Description 139
SKP-2075 – Product Status 139
SKP-2075 – Product Description 140
Veoli Ltd Pipeline Products & Ongoing Clinical Trials Overview 141
Cannabis Inhaler Device – Product Status 141
Cannabis Inhaler Device – Product Description 141
Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 142
RPL554 – Dry Powder Inhaler – Product Status 142
RPL554 – Dry Powder Inhaler – Product Description 142
Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 143
Drug Delivery Device – Cystic Fibrosis – Product Status 143
Drug Delivery Device – Cystic Fibrosis – Product Description 143
Dry Powder Inhaler – Product Status 144
Dry Powder Inhaler – Product Description 144
Glossary 208
